A Pan-Cancer Analysis Reveals CLEC5A as a Biomarker for Cancer Immunity and Prognosis

Chen, R; Wu, WT; Chen, SY; Liu, ZZ; Wen, ZP; Yu, J; Zhang, LB; Liu, ZQ; Zhang, J; Luo, P; Zeng, WJ; Cheng, Q

Cheng, Q (通讯作者)，Cent South Univ, Xiangya Hosp, Dept Neurosurg, Changsha, Peoples R China.;Zeng, WJ; Cheng, Q (通讯作者)，Cent South Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Changsha, Peoples R China.;Zeng, WJ (通讯作者)，Cent South Univ, Xiangya Hosp, Dept Pharm, Changsha, Peoples R China.

FRONTIERS IN IMMUNOLOGY, 2022; 13 ():

Abstract

BackgroundCLEC5A is a member of the C-type lectin superfamily. It can activate macrophages and lead to a series of immune-inflammation reactions. Prev......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索